Literature DB >> 30929020

WGS of 1058 Enterococcus faecium from Copenhagen, Denmark, reveals rapid clonal expansion of vancomycin-resistant clone ST80 combined with widespread dissemination of a vanA-containing plasmid and acquisition of a heterogeneous accessory genome.

Mette Pinholt1,2, Sion C Bayliss3, Heidi Gumpert1, Peder Worning1, Veronika V S Jensen4, Michael Pedersen1,5, Edward J Feil3, Henrik Westh1,2.   

Abstract

OBJECTIVES: From 2012 to 2015, a sudden significant increase in vancomycin-resistant (vanA) Enterococcus faecium (VREfm) was observed in the Capital Region of Denmark. Clonal relatedness of VREfm and vancomycin-susceptible E. faecium (VSEfm) was investigated, transmission events between hospitals were identified and the pan-genome and plasmids from the largest VREfm clonal group were characterized.
METHODS: WGS of 1058 E. faecium isolates was carried out on the Illumina platform to perform SNP analysis and to identify the pan-genome. One isolate was also sequenced on the PacBio platform to close the genome. Epidemiological data were collected from laboratory information systems.
RESULTS: Phylogeny of 892 VREfm and 166 VSEfm revealed a polyclonal structure, with a single clonal group (ST80) accounting for 40% of the VREfm isolates. VREfm and VSEfm co-occurred within many clonal groups; however, no VSEfm were related to the dominant VREfm group. A similar vanA plasmid was identified in ≥99% of isolates belonging to the dominant group and 69% of the remaining VREfm. Ten plasmids were identified in the completed genome, and ∼29% of this genome consisted of dispensable accessory genes. The size of the pan-genome among isolates in the dominant group was 5905 genes.
CONCLUSIONS: Most probably, VREfm emerged owing to importation of a successful VREfm clone which rapidly transmitted to the majority of hospitals in the region whilst simultaneously disseminating a vanA plasmid to pre-existing VSEfm. Acquisition of a heterogeneous accessory genome may account for the success of this clone by facilitating adaptation to new environmental challenges.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2019        PMID: 30929020     DOI: 10.1093/jac/dkz118

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  Trend of clinical vancomycin-resistant enterococci isolated in a regional Italian hospital from 2001 to 2018.

Authors:  Simona Fioriti; Serena Simoni; Sara Caucci; Gianluca Morroni; Elisa Ponzio; Sonia Nina Coccitto; Lucia Brescini; Oscar Cirioni; Stefano Menzo; Francesca Biavasco; Eleonora Giovanetti; Andrea Brenciani; Carla Vignaroli
Journal:  Braz J Microbiol       Date:  2020-08-11       Impact factor: 2.476

2.  No Effect of Lactobacillus rhamnosus GG on Eradication of Colonization by Vancomycin-Resistant Enterococcus faecium or Microbiome Diversity in Hospitalized Adult Patients.

Authors:  Ingrid Maria Cecilia Rubin; Sarah Mollerup; Christa Broholm; Signe Boye Knudsen; Adam Baker; Morten Helms; Mona Katrine Alberthe Holm; Thomas Kallemose; Henrik Westh; Jenny Dahl Knudsen; Mette Pinholt; Andreas Munk Petersen
Journal:  Microbiol Spectr       Date:  2022-04-27

3.  Surveillance of vancomycin-resistant enterococci reveals shift in dominating clones and national spread of a vancomycin-variable vanA Enterococcus faecium ST1421-CT1134 clone, Denmark, 2015 to March 2019.

Authors:  Anette M Hammerum; Ulrik S Justesen; Mette Pinholt; Louise Roer; Hülya Kaya; Peder Worning; Sanne Nygaard; Michael Kemp; Marianne Engell Clausen; Karen Leth Nielsen; Jurgita Samulioniené; Mona Kjærsgaard; Claus Østergaard; John Coia; Turid Snekloth Søndergaard; Shahin Gaini; Kristian Schønning; Henrik Westh; Henrik Hasman; Barbara Juliane Holzknecht
Journal:  Euro Surveill       Date:  2019-08

Review 4.  Genomics of vancomycin-resistant Enterococcus faecium.

Authors:  Claire Gorrie; Charlie Higgs; Glen Carter; Timothy P Stinear; Benjamin Howden
Journal:  Microb Genom       Date:  2019-07-22

5.  Impact of single-room contact precautions on acquisition and transmission of vancomycin-resistant enterococci on haematological and oncological wards, multicentre cohort-study, Germany, January-December 2016.

Authors:  Lena M Biehl; Paul G Higgins; Jannik Stemler; Meyke Gilles; Silke Peter; Daniela Dörfel; Wichard Vogel; Winfried V Kern; Hanna Gölz; Hartmut Bertz; Holger Rohde; Eva-Maria Klupp; Philippe Schafhausen; Jon Salmanton-García; Melanie Stecher; Julia Wille; Blasius Liss; Kyriaki Xanthopoulou; Janine Zweigner; Harald Seifert; Maria J G T Vehreschild
Journal:  Euro Surveill       Date:  2022-01

6.  Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.

Authors:  Sarah A Egan; Nicole L Kavanagh; Anna C Shore; Sarah Mollerup; José A Samaniego Castruita; Brian O'Connell; Brenda A McManus; Grainne I Brennan; Mette Pinholt; Henrik Westh; David C Coleman
Journal:  J Antimicrob Chemother       Date:  2022-02-02       Impact factor: 5.790

7.  The Role of Whole Genome Sequencing in the Surveillance of Antimicrobial Resistant Enterococcus spp.: A Scoping Review.

Authors:  Lindsay A Rogers; Kayla Strong; Susan C Cork; Tim A McAllister; Karen Liljebjelke; Rahat Zaheer; Sylvia L Checkley
Journal:  Front Public Health       Date:  2021-06-10

8.  Increase of vancomycin-resistant Enterococcus faecium strain type ST117 CT71 at Charité - Universitätsmedizin Berlin, 2008 to 2018.

Authors:  Anna Weber; Friederike Maechler; Frank Schwab; Petra Gastmeier; Axel Kola
Journal:  Antimicrob Resist Infect Control       Date:  2020-07-16       Impact factor: 4.887

9.  Mode and dynamics of vanA-type vancomycin resistance dissemination in Dutch hospitals.

Authors:  Sergio Arredondo-Alonso; Janetta Top; Jukka Corander; Rob J L Willems; Anita C Schürch
Journal:  Genome Med       Date:  2021-01-20       Impact factor: 11.117

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.